GSK narrowly defeats ACCC’s case over revised Osteo Gel packaging
Bird & Bird 2019-05-17 11:44 pm | Melbourne
GlaxoSmithKline has defeated claims by the ACCC that revised packaging for its now-discontinued pain killer Osteo Gel misled consumers. The drug maker will face penalties for earlier violations it admitted to, but the court hinted the damages will be nowhere near the $6 million competitor Reckitt Benckiser faced in a similar case.